Details for 2021750441

Up to date per 30.04.2026

Actions

Title / Product Name

AMISELIMOD ZUR VERWENDUNG BEI DER BEHANDLUNG VON MYALGISCHER ENZEPHALOMYELITIS/CHRONISCHEM MÜDIGKEITSSYNDROM

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2021750441

EP Publication Number

4101445

E-Number

1789401

Language

PCT Number

JP21004216

Publication Date

14.12.2022 A

30.04.2025 B1

Registration Date

30.04.2025

AT Publication Date

15.05.2025

Application Date

05.02.2021

Registration Number

Priorities

06.02.2020

2020019153

IPC

A61K 31/137 20060101AFI20230511BHEP

Maximum Duration of Protection

05.02.2041

Owner

Mitsubishi Tanabe Pharma Corporation3-2-10, Dosho-machi, Chuo-ku, Osaka-shi, Osaka 541-8505JP

Representative

No representatives present

Inventor

IZAKI, Hitoshic/o MITSUBISHI TANABE PHARMA CORPORATION 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

HAYASHI, Rikakoc/o MITSUBISHI TANABE PHARMA CORPORATION 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP

YANAI, Yoshiaric/o MITSUBISHI TANABE PHARMA CORPORATION 3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505JP